Microbiology
-
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
This article has 35 authors:Reviewed by ScreenIT
-
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
This article has 10 authors:Reviewed by ScreenIT
-
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
This article has 6 authors:Reviewed by ScreenIT
-
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
This article has 34 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
This article has 12 authors:Reviewed by ScreenIT
-
Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig
This article has 15 authors:Reviewed by ScreenIT
-
A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity
This article has 5 authors:Reviewed by ScreenIT
-
Evaluation of heating and chemical protocols for inactivating SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing
This article has 4 authors:Reviewed by ScreenIT